Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species.

Hensley LE, Mulangu S, Asiedu C, Johnson J, Honko AN, Stanley D, Fabozzi G, Nichol ST, Ksiazek TG, Rollin PE, Wahl-Jensen V, Bailey M, Jahrling PB, Roederer M, Koup RA, Sullivan NJ.

PLoS Pathog. 2010 May 20;6(5):e1000904. doi: 10.1371/journal.ppat.1000904.

2.

Vaccines against 'the other' Ebolavirus species.

Kozak RA, Kobinger GP.

Expert Rev Vaccines. 2016 Sep;15(9):1093-100. doi: 10.1586/14760584.2016.1170597. Epub 2016 Apr 12. Review.

PMID:
27010528
3.

[Overview of Ebola virus vaccine].

Yang L, Li J, Gao GF, Liu W.

Sheng Wu Gong Cheng Xue Bao. 2015 Jan;31(1):1-23. Review. Chinese.

PMID:
26021076
4.

Immunology of protection from Ebola virus infection.

Krause PR, Bryant PR, Clark T, Dempsey W, Henchal E, Michael NL, Regules JA, Gruber MF.

Sci Transl Med. 2015 May 6;7(286):286ps11. doi: 10.1126/scitranslmed.aaa8202. Review.

PMID:
25947159
5.

Recent advances in the development of vaccines for Ebola virus disease.

Ohimain EI.

Virus Res. 2016 Jan 4;211:174-85. doi: 10.1016/j.virusres.2015.10.021. Epub 2015 Oct 24. Review.

PMID:
26596227
6.

Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine.

Zhou Y, Sullivan NJ.

Curr Opin Immunol. 2015 Aug;35:131-6. doi: 10.1016/j.coi.2015.06.006. Epub 2015 Aug 3. Review.

PMID:
26247875
7.

Ebolavirus Vaccines: Progress in the Fight Against Ebola Virus Disease.

Wu XX, Yao HP, Wu NP, Gao HN, Wu HB, Jin CZ, Lu XY, Xie TS, Li LJ.

Cell Physiol Biochem. 2015;37(5):1641-58. doi: 10.1159/000438531. Epub 2015 Nov 5. Review.

8.

Ebola virus vaccines: an overview of current approaches.

Marzi A, Feldmann H.

Expert Rev Vaccines. 2014 Apr;13(4):521-31. doi: 10.1586/14760584.2014.885841. Epub 2014 Feb 27. Review.

9.

Rethinking the Response to Emerging Microbes: Vaccines and Therapeutics in the Ebola Era--a Conference at Harvard Medical School.

Knipe DM, Whelan SP.

J Virol. 2015 Aug;89(15):7446-8. doi: 10.1128/JVI.01251-15. Epub 2015 May 20.

10.

Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever.

Warfield KL, Olinger GG.

J Biomed Biotechnol. 2011;2011:984241. doi: 10.1155/2011/984241. Epub 2011 Dec 28. Review.

11.

Ebolavirus vaccines for humans and apes.

Fausther-Bovendo H, Mulangu S, Sullivan NJ.

Curr Opin Virol. 2012 Jun;2(3):324-9. doi: 10.1016/j.coviro.2012.04.003. Epub 2012 May 4. Review.

12.

Current ebola vaccines.

Hoenen T, Groseth A, Feldmann H.

Expert Opin Biol Ther. 2012 Jul;12(7):859-72. doi: 10.1517/14712598.2012.685152. Epub 2012 May 5. Review.

13.

[Research progress on ebola virus glycoprotein].

Ding GY, Wang ZY, Gao L, Jiang BF.

Bing Du Xue Bao. 2013 Mar;29(2):233-7. Review. Chinese.

PMID:
23757858
14.

Development of vaccines for prevention of Ebola virus infection.

Ye L, Yang C.

Microbes Infect. 2015 Feb;17(2):98-108. doi: 10.1016/j.micinf.2014.12.004. Epub 2014 Dec 16. Review.

PMID:
25526819
15.

Ebola virus vaccines - reality or fiction?

Mire CE, Geisbert TW, Feldmann H, Marzi A.

Expert Rev Vaccines. 2016 Nov;15(11):1421-1430. Epub 2016 May 9. Review.

16.

[Recent Advances in Vaccines and Drugs Against the Ebola Virus].

Zhu X, Yao C, Wei Y, Kou Z, Hu K.

Bing Du Xue Bao. 2015 May;31(3):287-92. Review. Chinese.

PMID:
26470536
17.

Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule.

Sullivan NJ, Martin JE, Graham BS, Nabel GJ.

Nat Rev Microbiol. 2009 May;7(5):393-400. doi: 10.1038/nrmicro2129. Review. Erratum in: Nat Rev Microbiol. 2009 Sep;7(9):684.

PMID:
19369954
18.
19.

Ebola virus vaccines: Where do we stand?

Pavot V.

Clin Immunol. 2016 Dec;173:44-49. doi: 10.1016/j.clim.2016.10.016. Epub 2016 Oct 28. Review.

PMID:
27910805
20.

Molecular mechanisms of Ebola pathogenesis.

Rivera A, Messaoudi I.

J Leukoc Biol. 2016 Nov;100(5):889-904. Epub 2016 Sep 1. Review.

Supplemental Content

Support Center